Report of Foreign Issuer (6-k)
February 23 2018 - 12:52PM
Edgar (US Regulatory)
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Month of February, 2018
Commission File Number: 001-35892
GW PHARMACEUTICALS PLC
(Translation of registrant’s name
into English)
Sovereign House
Vision Park
Histon
Cambridge CB24 9BZ
United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Other Events
On February 21, 2018, GW Pharmaceuticals
plc (the “Company”) issued a press release announcing that a Phase 2a proof of concept study of a pipeline compound
GWP42006 in adult patients with focal seizures did not meet its primary endpoint. GWP42006 is also being developed within the field
of autism spectrum disorders (ASD) which will represent an increased therapeutic focus for ongoing development of this pipeline
compound. The press release is attached as Exhibit 99.1 and is incorporated by reference herein. The information contained
in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, unless expressly set forth by specific reference in such a filing.
Exhibits
99.1 Press Release dated February 21, 2018
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
GW Pharmaceuticals plc
|
|
|
|
|
By:
|
/s/ Adam George
|
|
Name:
|
Adam George
|
|
Title:
|
Secretary
|
|
|
|
Date: February 23, 2018
|
|
|